Clarivate Plc (CLVT)
NYSE:CLVT
Want to see CLVT full AI Analyst Report?
CLVT Stock Chart & Stats
$2.68
-$0.17(-3.38%)
At close: 4:00 PM EST
$2.68
-$0.17(-3.38%)
Day’s Range― - ―
52-Week Range$1.66 - $4.77
Previous CloseN/A
Volume814.08K
Average Volume (3M)4.94M
Market Cap
$1.57B
Enterprise Value$5.67B
Total Cash (Recent Filing)$232.30M
Total Debt (Recent Filing)$4.33B
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Aug 11, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding639,216,500
10 Day Avg. Volume4,577,056
30 Day Avg. Volume4,942,091
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.46
Price to Sales (P/S)0.92
P/FCF Ratio6.16
Enterprise Value/Market Cap3.62
Enterprise Value/Revenue2.32
Enterprise Value/Gross Profit3.48
Enterprise Value/Ebitda6.45
Forecast
1Y Price Target
$3.46Price Target Upside29.10% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)0.75
Revenue Forecast (FY)$2.36B
Bulls Say, Bears Say
Bulls Say
Business StrategyCLVT has restructured its business model to focus on recurring revenue streams, which is expected to provide more stability in revenue.
Financial GuidanceManagement raised full-year revenue guidance due to improved organic growth outlook and favorable FX rates.
Revenue PerformanceClarivate's third-quarter revenue exceeded estimates by $53 million, driven by higher-than-expected transactional revenues.
Bears Say
Growth RisksThe largest risks to CLVT's growth prospect include AI disintermediation, high leverage, and execution on its value creation plan.
ProfitabilityAdjusted EBITDA margin fell short of the model by 140 basis points.
Revenue StabilityRecurring revenue fell short, coming in 70 basis points below the model.
Clarivate News
CLVT FAQ
What was Clarivate Plc’s price range in the past 12 months?
Clarivate Plc lowest stock price was $1.66 and its highest was $4.77 in the past 12 months.
What is Clarivate Plc’s market cap?
Clarivate Plc’s market cap is $1.57B.
When is Clarivate Plc’s upcoming earnings report date?
Clarivate Plc’s upcoming earnings report date is Aug 11, 2026 which is in 79 days.
How were Clarivate Plc’s earnings last quarter?
Clarivate Plc released its earnings results on Apr 29, 2026. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.145 by $0.035.
Is Clarivate Plc overvalued?
According to Wall Street analysts Clarivate Plc’s price is currently Undervalued.
Does Clarivate Plc pay dividends?
Clarivate Plc does not currently pay dividends.
What is Clarivate Plc’s EPS estimate?
Clarivate Plc’s EPS estimate is 0.18.
How many shares outstanding does Clarivate Plc have?
Clarivate Plc has 639,216,500 shares outstanding.
What happened to Clarivate Plc’s price movement after its last earnings report?
Clarivate Plc reported an EPS of $0.18 in its last earnings report, beating expectations of $0.145. Following the earnings report the stock price went up 13.944%.
Which hedge fund is a major shareholder of Clarivate Plc?
Currently, no hedge funds are holding shares in CLVT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clarivate Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.46 (29.10% Upside)
$3.46 (29.10% Upside)
Blogger Sentiment
Bullish
CLVT Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 273.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.52%
12-Months-Change
Fundamentals
Return on Equity
-2.81%
Trailing 12-Months
Asset Growth
-4.92%
Trailing 12-Months
Company Description
Clarivate Plc
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
CLVT Company Deck
CLVT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mix of constructive operational and financial progress alongside material near-term headwinds. Highlights include margin expansion (adjusted EBITDA margin up ~200 bps to 41%), improved subscription mix (roughly 88%–89%), strengthened renewal discipline (+100 bps), AI-driven product adoption and efficiency gains, debt reduction actions and a reaffirmed full-year guidance with anticipated free cash flow growth to ~$400M. Offsetting these positives are modest organic growth rates (organic ACV 1.6%), Q1 free cash flow down $31M, transactional revenue softness, planned revenue reductions from disposals (~$100–130M), first-half timing pressure in patent renewals, and a potentially large cash tax increase disclosed in the call, which introduces meaningful near-term cash risk and uncertainty. Overall, the improvement trajectory and margin/cash generation outlook are encouraging, but the modest growth rates and several notable risks keep the picture balanced.View all CLVT earnings summariesCLVT Stock 12 Month Forecast
Average Price Target
$3.46
▲(29.10% Upside)
Technical Analysis
Ownership Overview
5.93% Insiders
9.59% Mutual Funds
67.13% Other Institutional Investors
8.64% Public Companies and
Individual Investors